The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Open accessAbstract
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all‐cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A consensus meeting was held among the study neurologists and neuropsychologists to clinically determine each potential participant’s cognitive status grouping (NC, MCI, or dementia) based on a standardized approach used in National Institute of Health (NIH)-funded Alzheimer’s Disease Centers across the United States (Albert et al., 2011; Jack et al., 2011; McKhann et al., 2011).”
From Internet-Based Conversational Engagement Randomized Controlled Clinical Trial (I-CONECT) Among Socially Isolated Adults 75+ Years Old With Normal Cognition or Mild Cognitive Impairment: Topline Results (2024) · cites this paper as McKhann et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the atrophy of specific brain regions shown by structural MRI is an important part of the diagnostic criteria for FTD and AD (McKhann et al., 2011; Rascovsky et al., 2011)”
From Deep Learning-Based Classification and Voxel-Based Visualization of Frontotemporal Dementia and Alzheimer's Disease (2021) · cites this paper as McKhann et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diagnosis of AD was made in accordance with the NINCDS-ADRCA criteria (McKhann et al., 2011) and MCI was diagnosed according to the Mayo criteria (Petersen et al., 1999).”
From Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction (2018) · cites this paper as McKhann et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During this extended preclinical period prior to the dementia diagnosis, many patients develop behavioral or neuropsychiatric changes, including agitation, irritability, decreased motivation, loss of empathy, and depression, which increase the risk of transition to mild cognitive impairment and AD.12-14”
From Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“All patients (n = 96) were clinically evaluated by expert neurologists (M.G., D.J.I.) at the time of recording at the frontotemporal degeneration center (FTDC) in the neurology department of the Hospital of the University of Pennsylvania, and they were classified at a weekly consensus meeting at the FTDC using established clinical criteria.”
From Automatic classification of AD pathology in FTD phenotypes using natural speech (2024) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“AD is clinically diagnosed using the 2011 National Institute on Aging-Alzheimer's Association (NIA-AA) criteria [5].”
From Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer’s disease: findings based on urine proteomics and machine learning (2023) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Probable AD diagnoses were assigned according to both NINCDS/ADRDA criteria (23), and the core clinical NIA-AA criteria (28).”
From SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease (2014) · cites this paper as [28]
In the citing paper
“The University of California San Francisco (UCSF) Memory and Aging Center Dementia cohort consisted of 152 carefully phenotyped older adults meeting the National Institute on Aging-Alzheimer's Association (NIA-AA) criteria for either mild-cognitive impairment22 or probable dementia because of AD.23”
From Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease (2015) · cites this paper as [23]
In the citing paper
“More recently, the imaging of amyloid with compounds such as the radiolabeled Pittsburgh compound B (11C-PiB) has received much interest and been proposed as a biomarker of AD.21,22”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [21]
In the citing paper
“These, along with amyloid imaging using positron emission tomography (PET), may help determine AD as the main or contributory cause of the cognitive disorder.”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [21]
In the citing paper
“CSF markers for AD are, however, better developed, with lower levels of Aβ42 and elevated levels of tau/phosphorylated-tau being indicative of AD pathology.21,22”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [21]
In the citing paper
“The clinical criteria used most commonly are the NIA‐AA criteria for dementia 89 and mild cognitive impairment 90 due to Alzheimer's disease.”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [89]
In the citing paper
“The development of the DSM-5 criteria for the various subtypes involved extensive discussions with experts from diverse fields to harmonize the DSM criteria with criteria developed by other expert groups, such as the NIA-AA, 20,27 the frontotemporal dementia expert group, 28,29 the consortium on DLB, 30 the VASCOG working group, 31 the Movement Disorder Study Task Force on Parkinson Disease 32 and”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [27]
In the citing paper
“This different pattern of results in bvFTD and AD may reflect the preferential and widespread damage within the AIN in bvFTD11,14,16, 17, 18, 19, 20,24 whereas in AD, AIN damage appears to be more circumscribed.17,38,88”
From Altered spatiotemporal brain dynamics of interoception in behavioural-variant frontotemporal dementia (2025) · cites this paper as [38]
In the citing paper
“Second, patients received diagnoses based on established clinical criteria only,37,38 without testing for ATN biomarkers in AD such as the deposition of amyloid-β and tau proteins established via Positron Emission Tomography, CSF, or plasma in AD.94, 95, 96, 97”
From Altered spatiotemporal brain dynamics of interoception in behavioural-variant frontotemporal dementia (2025) · cites this paper as [38]
In the citing paper
“The diagnosis was concluded in a multidisciplinary meeting using consensus criteria for probable FTD, PPD (DSM-V), and AD [25,31,32].”
In the citing paper
“Detection of abnormal Aβ accumulation (Aβ positivity) may support the clinical diagnosis of AD1,2 and is essential for including participants in clinical AD trials targeting Aβ.3”
From Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status (2019) · cites this paper as [2]
In the citing paper
“Diagnosis was established by the multidisciplinary teams at each research institute based on current consensus diagnostic criteria (McKhann et al., 2011; Postuma et al., 2015; Rascovsky et al., 2011).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as McKhann et al., 2011
In the citing paper
“AD patients present with predominant episodic memory loss and impaired executive functioning, with atrophy observed in the medial temporal lobe, most notably in the hippocampus and posterior cingulate (McKhann et al., 2011).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as McKhann et al., 2011
In the citing paper
“A diagnosis of probable AD had been made prior to the study by neurologists at the Memory Center according to the clinical criteria of the National Institute on Aging and the Alzheimer’s Association criteria for probable AD [1].”
From The effects of confinement on neuropsychiatric symptoms in Alzheimer's disease during the COVID-19 crisis (2020) · cites this paper as [1]
In the citing paper
“The 3 major clinical criteria for the AD spectrum are the revised 2011 NIA-AA criteria, 32,39 the International Working Group (Dubois and colleagues 39,40 ) 2010 revised new lexicon criteria, and the Diagnostic and Statistical Manual of Mental Disorders, 5th edition criteria.41”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [32]
In the citing paper
“The 2011 National Institute on Aging and Alzheimer's Association (NIA-AA) criteria for AD recognizes nonamnestic AD presentations that include language, visuospatial, and executive dysfunction features.32”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [32]
In the citing paper
“dementia-level impairment requires cognitive or behavioral symptoms”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [32]
In the citing paper
“MCI diagnosis is a matter of”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [32]
In the citing paper
“With the advent of biomarkers that enable in vivo identification of underlying AD pathological conditions, and the acceptance that AD begins years before the emergence of cognitive impairment, AD is now commonly accepted as a clinicopathological entity7,8 that can be diagnosed without histopathological examination, in the presence of appropriate biomarker evidence of an underlying condition.6,8,9”
From Positron Emission Tomography Imaging With [ 18 F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes (2020) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Self-citationAlbert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · cited 7×
“Initial efforts to incorporate biomarkers into the diagnosis of AD dementia and MCI [14] need to be coupled with a more comprehensive approach to the diagnostic process.”
BackgroundInfluentialSelf-citationMild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Self-citationRomán, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Flagged first, then by citations
Cited by
Sorted by citations
Items 1,301–1,400 of 1,532
A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging
Hayden, K. M., McEvoy, J. M., Linnertz, C., Attix, D., Kuchibhatla, M., Saunders, A. M., Lutz, M. W., Welsh‐Bohmer, K. A., Roses, A. D., & Chiba‐Falek, O. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.005 · Cited by 53
Ma, L., Chen, J., Wang, R., Han, Y., Zhang, J., Dong, W., Zhang, X., Wu, Y., & Zhao, Z. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.10.011 · Cited by 53
Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease
Oveisgharan, S., Yang, J., Yu, L., Burba, D., Bang, W., Tasaki, S., Grodstein, F., Wang, Y., Zhao, J., De Jager, P. L., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000206833 · Cited by 53
Orimaye, S. O., Wong, J. S.-M., & Wong, C. P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0205636 · Cited by 52
Higher-order spectral analysis of spontaneous speech signals in Alzheimer’s disease
Nasrolahzadeh, M., Mohammadpoory, Z., & Haddadnia, J. (2018) · Cognitive Neurodynamics · doi:10.1007/s11571-018-9499-8 · Cited by 51
Reda, F., Gorgoni, M., Lauri, G., Truglia, I., Cordone, S., Scarpelli, S., Mangiaruga, A., D'Atri, A., Ferrara, M., Lacidogna, G., et al. (2017) · Brain Sciences · doi:10.3390/brainsci7050051 · Cited by 52
Begcevic, I., Tsolaki, M., Brinc, D., Brown, M., Martinez-Morillo, E., Lazarou, I., Kozori, M., Tagaraki, F., Nenopoulou, S., Gkioka, M., et al. (2018) · F1000Research · doi:10.12688/f1000research.15095.1 · Cited by 51
The DELCODE Study Group, Brueggen, K., Dyrba, M., Cardenas-Blanco, A., Schneider, A., Fliessbach, K., Buerger, K., Janowitz, D., Peters, O., Menne, F., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09429-3 · Cited by 51
Bangen, K. J., Initiative, F. T. A. D. N., Clark, A. L., Werhane, M., Edmonds, E. C., Nation, D. A., Evangelista, N., Libon, D. J., Bondi, M. W., & Delano-Wood, L. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150900 · Cited by 51
Dalmasso, M. C., Brusco, L. I., Olivar, N., Muchnik, C., Hanses, C., Milz, E., Becker, J., Heilmann-Heimbach, S., Hoffmann, P., Prestia, F. A., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0394-9 · Cited by 51
Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments
Gao, C., Li, B., He, Y., Huang, P., Du, J., He, G., Zhang, P., Tang, H., & Chen, S. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14252 · Cited by 50
Papma, J. M., den Heijer, T., de Koning, I., Mattace-Raso, F. U., van der Lugt, A., van der Lijn, F., van Swieten, J. C., Koudstaal, P. J., Smits, M., & Prins, N. D. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2012.11.005 · Cited by 48
Chaaya, M., Phung, T. K. T., El Asmar, K., Atweh, S., Ghusn, H., Khoury, R. M., Prince, M., Nielsen, T. R., & Waldemar, G. (2016) · Aging & Mental Health · doi:10.1080/13607863.2015.1043620 · Cited by 51
Lexical and Acoustic Speech Features Relating to Alzheimer Disease Pathology
Cho, S., Cousins, K. A. Q., Shellikeri, S., Ash, S., Irwin, D. J., Liberman, M. Y., Grossman, M., & Nevler, N. (2022) · Neurology · doi:10.1212/wnl.0000000000200581 · Cited by 51
Chatterjee, M., Özdemir, S., Kunadt, M., Koel‐Simmelink, M., Boiten, W., Piepkorn, L., Pham, T. V., Chiasserini, D., Piersma, S. R., Knol, J. C., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13066 · Cited by 47
Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu372 · Cited by 49
Self-citationFitz, N. F., Wang, J., Kamboh, M. I., Koldamova, R., & Lefterov, I. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105481 · Cited by 49
“These criteria are similar to those proposed by the NIA-AA work group (McKhann et al., 2011).”
Gossink, F., Schouws, S., Krudop, W., Scheltens, P., Stek, M., Pijnenburg, Y., & Dols, A. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.12.008 · Cited by 49
Self-citationFalgàs, N., Sánchez-Valle, R., Bargalló, N., Balasa, M., Fernández-Villullas, G., Bosch, B., Olives, J., Tort-Merino, A., Antonell, A., Muñoz-García, C., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101927 · Cited by 47
Altered gut microbiota in older adults with mild cognitive impairment: a case-control study
Fan, K.-C., Lin, C.-C., Liu, Y.-C., Chao, Y.-P., Lai, Y.-J., Chiu, Y.-L., & Chuang, Y.-F. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1162057 · Cited by 47
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD
Gross, A. L., Walker, K. A., Moghekar, A. R., Pettigrew, C., Soldan, A., Albert, M. S., & Walston, J. D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00229 · Cited by 49
Liu, F., Sun, J., Wang, X., Jin, S., Sun, F., Wang, T., Yuan, B., Qiu, W., & Ma, C. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00927-5 · Cited by 48
Ray, N. J., Metzler-Baddeley, C., Khondoker, M. R., Grothe, M. J., Teipel, S., Wright, P., Heinsen, H., Jones, D. K., Aggleton, J. P., & O'Sullivan, M. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3617-14.2015 · Cited by 48
The Link Between C-Reactive Protein and Alzheimer's Disease Among Mexican Americans
O'Bryant, S. E., for the Texas Alzheimer's Research & Care Consortium, Johnson, L., Edwards, M., Soares, H., Devous, M. D., Ross, S., Rohlfing, G., & Hall, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122071 · Cited by 47
Risk of dementia and mild cognitive impairment among older adults in same‐sex relationships
Perales‐Puchalt, J., Gauthreaux, K., Flatt, J., Teylan, M. A., Resendez, J., Kukull, W. A., Chan, K. C. G., Burns, J., & Vidoni, E. D. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5092 · Cited by 47
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project
Initiative, F. T. A. D. N., van Maurik, I. S., Slot, R. E. R., Verfaillie, S. C. J., Zwan, M. D., Bouwman, F. H., Prins, N. D., Teunissen, C. E., Scheltens, P., Barkhof, F., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0487-y · Cited by 47
Self-citationDialogue Systems and Conversational Agents for Patients with Dementia: The Human–Robot Interaction
Russo, A., D'Onofrio, G., Gangemi, A., Giuliani, F., Mongiovi, M., Ricciardi, F., Greco, F., Cavallo, F., Dario, P., Sancarlo, D., et al. (2019) · Rejuvenation Research · doi:10.1089/rej.2018.2075 · Cited by 47
Song, M.-K., Ward, S. E., Hepburn, K., Paul, S., Kim, H., Shah, R. C., Morhardt, D. J., Medders, L., Lah, J. J., & Clevenger, C. C. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2019.0088 · Cited by 47
A remote speech-based AI system to screen for early Alzheimer's disease via smartphones
Fristed, E., Skirrow, C., Meszaros, M., Lenain, R., Meepegama, U., Cappa, S., Aarsland, D., & Weston, J. (2022) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12366 · Cited by 47
Mirkin, S., & Albensi, B. C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1094233 · Cited by 46
Novelli, M. M. P. C., Machado, S. C. B., Lima, G. B., Cantatore, L., Sena, B. P., Rodrigues, R. S., Rodrigues, C. I. B., Canon, M. B. F., Piersol, C. V., Nitrini, R., et al. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000256 · Cited by 46
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD expert meeting
Robert, P. H., Konig, A., Andrieu, S., Bremond, F., Chemin, I., Chung, P. C., Dartigues, J. F., Dubois, B., Feutren, G., Guillemaud, R., et al. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0046-3 · Cited by 46
Vijverberg, E. G. B., Dols, A., Krudop, W. A., Del Campo Milan, M., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., Teunissen, C. E., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.009 · Cited by 46
Self-citationKinetics and 28-day test–retest repeatability and reproducibility of [ 11 C]UCB-J PET brain imaging
Tuncel, H., Boellaard, R., Coomans, E. M., de Vries, E. F., Glaudemans, A. W., Feltes, P. K., García, D. V., Verfaillie, S. C., Wolters, E. E., Sweeney, S. P., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20964248 · Cited by 45
Self-citationPhung, T. K. T., Chaaya, M., Asmar, K., Atweh, S., Ghusn, H., Khoury, R. M., Prince, M., & Waldemar, G. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437092 · Cited by 44
Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies
van der Zande, J. J., Gouw, A. A., van Steenoven, I., van de Beek, M., Scheltens, P., Stam, C. J., & Lemstra, A. W. (2020) · Neurology · doi:10.1212/wnl.0000000000009977 · Cited by 43
Self-citationAdvanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01330-y · Cited by 48
Casaletto, K. B., Staffaroni, A. M., Elahi, F., Fox, E., Crittenden, P. A., You, M., Neuhaus, J., Glymour, M., Bettcher, B. M., Yaffe, K., et al. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.05.004 · Cited by 47
Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease
Lillenes, M. S., Rabano, A., Støen, M., Riaz, T., Misaghian, D., Møllersen, L., Esbensen, Y., Günther, C.-C., Selnes, P., Stenset, V. T. V., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0237-z · Cited by 46
Dementia ConnEEGtome: towards multicentric harmonization of EEG connectivity in neurodegeneration
Prado, P., Birba, A., Cruzat, J., Santamaría-García, H., Parra, M., Moguilner, S., Tagliazucchi, E., & Ibáñez, A. (2022) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2021.12.008 · Cited by 43
Chan, J. Y. C., Bat, B. K. K., Wong, A., Chan, T. K., Huo, Z., Yip, B. H. K., Kowk, T. C. Y., & Tsoi, K. K. F. (2022) · Neuropsychology Review · doi:10.1007/s11065-021-09523-2 · Cited by 43
Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies
Xhima, K., Markham-Coultes, K., Hahn Kofoed, R., Saragovi, H. U., Hynynen, K., & Aubert, I. (2022) · Brain · doi:10.1093/brain/awab460 · Cited by 43
Asken, B. M., Tanner, J. A., VandeVrede, L., Mantyh, W. G., Casaletto, K. B., Staffaroni, A. M., La Joie, R., Iaccarino, L., Soleimani-Meigooni, D., Rojas, J. C., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200678 · Cited by 40
Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy
Gauthreaux, K., Bonnett, T. A., Besser, L. M., Brenowitz, W. D., Teylan, M., Mock, C., Chen, Y.-C., Chan, K. C. G., Keene, C. D., Zhou, X.-H., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa014 · Cited by 44
Huynh, K., Piguet, O., Kwok, J., Dobson-Stone, C., Halliday, G. M., Hodges, J. R., & Landin-Romero, R. (2021) · Neurology · doi:10.1212/wnl.0000000000011638 · Cited by 43
Santacruz Escudero, J. M., Beltrán, J., Palacios, Á., Chimbí, C. M., Matallana, D., Reyes, P., Perez-Sola, V., & Santamaría-García, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00176 · Cited by 41
Impaired Cardiac Function and Cognitive Brain Aging
van der Velpen, I. F., Yancy, C. W., Sorond, F. A., & Sabayan, B. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.07.008 · Cited by 41
Vijverberg, E. G. B., Dols, A., Krudop, W. A., Peters, A., Kerssens, C. J., van Berckel, B. N. M., Wattjes, M. P., Barkhof, F., Gossink, F., Prins, N. D., et al. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000444849 · Cited by 40
Self-citationWhite matter microstructural damage in Alzheimer's disease at different ages of onset
Canu, E., Agosta, F., Spinelli, E. G., Magnani, G., Marcone, A., Scola, E., Falautano, M., Comi, G., Falini, A., & Filippi, M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.026 · Cited by 42
Verfaillie, S. C. J., Slot, R. E., Tijms, B. M., Bouwman, F., Benedictus, M. R., Overbeek, J. M., Koene, T., Vrenken, H., Scheltens, P., Barkhof, F., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.009 · Cited by 40
Self-citationSelf-reported sleep disturbance and incidence of dementia in ageing men
Luojus, M. K., Lehto, S. M., Tolmunen, T., Brem, A.-K., Lönnroos, E., & Kauhanen, J. (2017) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2016-207764 · Cited by 42
Jiskoot, L. C., Poos, J. M., Vollebergh, M. E., Franzen, S., van Hemmen, J., Papma, J. M., van Swieten, J. C., Kessels, R. P. C., & van den Berg, E. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10096-y · Cited by 42
Simon, S. S., Tusch, E. S., Feng, N. C., Håkansson, K., Mohammed, A. H., & Daffner, K. R. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180455 · Cited by 42
Diagnostic biomarkers in Alzheimer’s disease
Andersen, E., Casteigne, B., Chapman, W. D., Creed, A., Foster, F., Lapins, A., Shatz, R., & Sawyer, R. P. (2021) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2021.100041 · Cited by 42
Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease
Shi, M., Tang, L., Toledo, J. B., Ginghina, C., Wang, H., Aro, P., Jensen, P. H., Weintraub, D., Chen‐Plotkin, A. S., Irwin, D. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.015 · Cited by 42
Smith, G., Chandler, M., Locke, D. E., Fields, J., Phatak, V., Crook, J., Hanna, S., Lunde, A., Morris, M., Graff-Radford, M., et al. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8103 · Cited by 42
The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease
Mohammad Shehata, I., Masood, W., Nemr, N., Anderson, A., Bhusal, K., Edinoff, A. N., Cornett, E. M., Kaye, A. M., & Kaye, A. D. (2022) · Neurology International · doi:10.3390/neurolint14020025 · Cited by 41
Larouche, E., Hudon, C., & Goulet, S. (2019) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2018.11.008 · Cited by 41
Panza, F., Seripa, D., Lozupone, M., Solfrizzi, V., Imbimbo, B. P., Barulli, M. R., Tortelli, R., Capozzo, R., Bisceglia, P., Dimitri, A., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1389885 · Cited by 41
Müller, M., Kuiperij, H. B., Versleijen, A. A. M., Chiasserini, D., Farotti, L., Baschieri, F., Parnetti, L., Struyfs, H., De Roeck, N., Luyckx, J., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160038 · Cited by 41
Dauwan, M., Linszen, M. M. J., Lemstra, A. W., Scheltens, P., Stam, C. J., & Sommer, I. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.013 · Cited by 37
Self-citationChang, Y., Fennema‐Notestine, C., Holland, D., McEvoy, L. K., Stricker, N. H., Salmon, D. P., Dale, A. M., Bondi, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1763 · Cited by 39
Visuospatial dysfunction in Alzheimer's disease and behavioural variant frontotemporal dementia
Salimi, S., Irish, M., Foxe, D., Hodges, J. R., Piguet, O., & Burrell, J. R. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.04.019 · Cited by 40
Iaccarino, L., Sala, A., Caminiti, S. P., Presotto, L., Perani, D., & Initiative, F. T. A. D. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190954 · Cited by 40
Belbin, O., Xiao, M.-F., Xu, D., Carmona-Iragui, M., Pegueroles, J., Benejam, B., Videla, L., Fernández, S., Barroeta, I., Nuñez-Llaves, R., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00398-0 · Cited by 39
Hazelton, J. L., Fittipaldi, S., Fraile-Vazquez, M., Sourty, M., Legaz, A., Hudson, A. L., Cordero, I. G., Salamone, P. C., Yoris, A., Ibañez, A., et al. (2023) · Cortex · doi:10.1016/j.cortex.2023.02.009 · Cited by 39
Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease
Caraci, F., Nicoletti, F., & Copani, A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.12.001 · Cited by 37
MRI assessment of whole-brain structural changes in aging
Guo, H., Siu, W., D’Arcy, R., Black, S., Grajauskas, L., Singh, S., Zhang, Y., Rockwood, K., & Song, X. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s139515 · Cited by 39
Longitudinal memory profiles in behavioral-variant frontotemporal dementia and Alzheimer’s disease
Schubert, S., Leyton, C. E., Hodges, J. R., & Piguet, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150802 · Cited by 37
Koh, S.-H., Kwon, H. S., Choi, S. H., Jeong, J. H., Na, H. R., Lee, C. N., Yang, Y., Lee, A. Y., Lee, J.-H., Park, K. W., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00803-w · Cited by 39
Ghosh, A., Puthusseryppady, V., Chan, D., Mascolo, C., & Hornberger, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06899-w · Cited by 39
Martínez de Toda, I., Miguélez, L., Vida, C., Carro, E., & De la Fuente, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190198 · Cited by 40
Lim, B., Sando, S. B., Grøntvedt, G. R., Bråthen, G., & Diamandis, E. P. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.013 · Cited by 39
Identifying functional cognitive disorder: a proposed diagnostic risk model
McWhirter, L., Ritchie, C., Stone, J., & Carson, A. (2022) · CNS Spectrums · doi:10.1017/s1092852921000845 · Cited by 40
Association of Hospitalization with Long‐Term Cognitive Trajectories in Older Adults
Sprung, J., Knopman, D. S., Petersen, R. C., Mielke, M. M., Weingarten, T. N., Vassilaki, M., Martin, D. P., Schulte, P. J., Hanson, A. C., Schroeder, D. R., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16909 · Cited by 39
Self-citationAtypical Alzheimer Disease Variants
Polsinelli, A. J., & Apostolova, L. G. (2022) · Continuum · doi:10.1212/con.0000000000001082 · Cited by 39
Chaudhry, A., & Rizig, M. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117270 · Cited by 37
Liew, T. M. (2021) · Age and Ageing · doi:10.1093/ageing/afab044 · Cited by 38
Pettigrew, C., Soldan, A., Moghekar, A., Wang, M.-C., Gross, A. L., O’Brien, R., & Albert, M. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.09.024 · Cited by 38
Biesbroek, J. M., Coenen, M., DeCarli, C., Fletcher, E. M., Maillard, P. M., Initiative, A. D. N., Barkhof, F., Barnes, J., Benke, T., Chen, C. P. L. H., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13765 · Cited by 38
EEG p-adic quantum potential accurately identifies depression, schizophrenia and cognitive decline
Shor, O., Glik, A., Yaniv-Rosenfeld, A., Valevski, A., Weizman, A., Khrennikov, A., & Benninger, F. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255529 · Cited by 38
Utility of quantitative EEG in early Lewy body disease
Massa, F., Meli, R., Grazzini, M., Famà, F., De Carli, F., Filippi, L., Arnaldi, D., Pardini, M., Morbelli, S., & Nobili, F. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.007 · Cited by 35
Al-Hameed, S., Benaissa, M., Christensen, H., Mirheidari, B., Blackburn, D., & Reuber, M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0217388 · Cited by 37
Impact of Comorbid Dementia on Patterns of Hospice Use
Aldridge, M. D., Hunt, L., Husain, M., Li, L., & Kelley, A. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0055 · Cited by 39
Jones, S. A., De Marco, M., Manca, R., Bell, S. M., Blackburn, D. J., Wilkinson, I. D., Soininen, H., & Venneri, A. (2019) · Cortex · doi:10.1016/j.cortex.2019.04.008 · Cited by 37
Carandini, T., Arighi, A., Sacchi, L., Fumagalli, G. G., Pietroboni, A. M., Ghezzi, L., Colombi, A., Scarioni, M., Fenoglio, C., De Riz, M. A., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0543-7 · Cited by 36
Aguilar, C., Muehlboeck, J.-S., Mecocci, P., Vellas, B., Tsolaki, M., Kloszewska, I., Soininen, H., Lovestone, S., Wahlund, L.-O., Simmons, A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00145 · Cited by 34
Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., Kumar, P., Turton, E. J., White, D. A., Serfaty, M. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00533-6 · Cited by 38
“It was not possible to mask the participants with motor neuron disease, caregivers, therapists, or treating clinicians due to the nature of the intervention.”
Legaz, A., Altschuler, F., Gonzalez-Gomez, R., Hernández, H., Baez, S., Migeot, J., Fittipaldi, S., Medel, V., Maito, M. A., Godoy, M. E., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00781-2 · Cited by 36
Patterns of Neuropsychological Impairment in Alzheimer’s Disease and Mixed Dementia
Dong, Y., Gan, D. Z. Q., Tay, S. Z., Koay, W. I., Collinson, S. L., Hilal, S., Venketasubramanian, N., & Chen, C. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.011 · Cited by 36
Bolsewig, K., Hok-A-Hin, Y. S., Sepe, F. N., Boonkamp, L., Jacobs, D., Bellomo, G., Paoletti, F. P., Vanmechelen, E., Teunissen, C. E., Parnetti, L., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220318 · Cited by 36
Abrevaya, S., Fittipaldi, S., García, A. M., Dottori, M., Santamaria-Garcia, H., Birba, A., Yoris, A., Hildebrandt, M. K., Salamone, P., De la Fuente, A., et al. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000868 · Cited by 34
Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases
Legaz, A., Abrevaya, S., Dottori, M., González Campo, C., Birba, A., Martorell Caro, M., Aguirre, J., Slachevsky, A., Aranguiz, R., Serrano, C., et al. (2022) · Brain · doi:10.1093/brain/awab345 · Cited by 34
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients
Sajjad, M. U., Blennow, K., Knapskog, A. B., Idland, A.-V., Chaudhry, F. A., Wyller, T. B., Zetterberg, H., & Watne, L. O. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190941 · Cited by 34
Chouinard, A.-M., Larouche, E., Audet, M.-C., Hudon, C., & Goulet, S. (2019) · Aging & Mental Health · doi:10.1080/13607863.2018.1484890 · Cited by 35
Deep grading for MRI-based differential diagnosis of Alzheimer’s disease and frontotemporal dementia
Nguyen, H.-D., Clément, M., Planche, V., Mansencal, B., & Coupé, P. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102636 · Cited by 35
Wang, Y., Sun, Y., Wang, Y., Jia, S., Qiao, Y., Zhou, Z., Shao, W., Zhang, X., Guo, J., Zhang, B., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01324-4 · Cited by 34
“Based on core clinical criteria for AD dementia, the patients are classified into probable AD dementia and possible AD dementia in clinical practice [5].”
MethodLang, F. M., Mo, Y., Sabbagh, M., Solomon, P., Boada, M., Jones, R. W., Frisoni, G. B., Grimmer, T., Dubois, B., Harnett, M., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12136 · Cited by 34
Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress
Keshavan, A., Heslegrave, A., Zetterberg, H., & Schott, J. M. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-016-0241-0 · Cited by 34
Zhang, H., Ni, M., Yang, Y., Xie, F., Wang, W., He, Y., Chen, W., & Chen, Z. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.107085 · Cited by 34
Metadata
- Authors
- McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., & Phelps, C. H.
- Affiliations
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Lady Davis Institute for Medical Research (CA)
- Harvard University (US)
- University of California, Irvine (US)
- University of Pittsburgh (US)
- National Institute of Neurological Disorders and Stroke (US)
- Columbia University Irving Medical Center (US)
- Eli Lilly (United States) (US)
- Washington University in St. Louis (US)
- UCL Queen Square Institute of Neurology (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Alzheimer's Association Chicago IL USA
- Alzheimer's Association (US)
- Department of Psychiatry Northwestern Feinberg School of Medicine Chicago IL USA
- National Institutes of Health (US)
- Corresponding author
- McKhann, Guy M.
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2011-04-22
- Volume
- 7
- Issue
- 3
- Pages
- 263-269
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC3312024
- OpenAlex
- W2115017507
- Semantic Scholar
- 37d2d04f8c09da1f0cf8434a38a51841b5b703bf
- Cited by
- 18,657
- References
- 44
- Citations by year
- 2026: 893 · 2025: 1313 · 2024: 1585 · 2023: 1543 · 2022: 1670 · 2021: 1796 · 2020: 1602 · 2019: 1448 · 2018: 1297 · 2017: 1200 · 2016: 1088 · 2015: 1062 · 2014: 794 · 2013: 715 · 2012: 491
- FWCI
- 471.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institute on Aging
- Forest Pharmaceuticals
- Alzheimer's Association
- Fidelity Biosciences
- Baxter International
- Pfizer
- Johnson and Johnson
- Avid Radiopharmaceuticals
- GE Healthcare
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, dementia diagnosis
- MeSH terms
- Alzheimer Disease, Diagnosis, Differential, Diagnostic Imaging, Humans, Societies, Medical, United States, Biomarkers, Practice Guidelines as Topic, Disease Progression, National Institute on Aging (U.S.)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
